Introducing of novel class of pyrano[2,3-c]pyrazole-5-carbonitrile analogs with potent antimicrobial activity, DNA gyrase inhibition, and prominent pharmacokinetic and CNS toxicity profiles supported by molecular dynamic simulation

References

• Abd El-Lateef, H. M., Elmaaty, A. A., Abdel Ghany, L. M. A., Abdel-Aziz, M. S., Zaki, I., & Ryad, N. (2023). Design and synthesis of 2-(4-bromophenyl)quinoline-4-carbohydrazide derivatives via molecular hybridization as novel microbial DNA-gyrase inhibitors. ACS Omega, 8(20), 17948–17965. https://doi.org/10.1021/acsomega.3c01156
   PubMed Web of Science ®Google Scholar
• Abd-El-Aziz, A. S., Alsaggaf, A. T., Okasha, R. M., Ahmed, H. E. A., Bissessur, R., Abdelghani, A. A., & Afifi, T. H. (2016). Antimicrobial and antitumor screening of fluorescent 5,7-dihydroxy-4-propyl-2H-chromen-2-one derivatives with docking studies. ChemistrySelect, 1(15), 5025–5033. https://doi.org/10.1002/slct.201600789
   Web of Science ®Google Scholar
• Afifi, T. H., Okasha, R. M., Ahmed, H. E., Ilaš, J., Saleh, T., & Abd-El-Aziz, A. (2017). Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents. EXCLI Journal, 16, 868.
   PubMed Web of Science ®Google Scholar
• Afifi, T. H., Okasha, R. M., Alsherif, H., Ahmed, H. E., & Abd-El-Aziz, A. S. (2017). Design, synthesis, and docking studies of 4H-chromene and chromene based azo chromophores: a novel series of potent antimicrobial and anticancer agents. Current Organic Synthesis, 14(7), 1036–1051. https://doi.org/10.2174/1570179414666170519150520
   Web of Science ®Google Scholar
• Ahmed, H. E. A., Ihmaid, S. K., Omar, A. M., Shehata, A. M., Rateb, H. S., Zayed, M. F., Ahmed, S., & Elaasser, M. M. (2018). Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents. Bioorganic Chemistry, 76, 332–342. https://doi.org/10.1016/j.bioorg.2017.11.019
   PubMed Web of Science ®Google Scholar
• Al-Harbi, L. M., Al-Harbi, E. A., Okasha, R. M., El-Eisawy, R. A., El-Nassag, M. A. A., Mohamed, H. M., Fouda, A. M., Elhenawy, A. A., Mora, A., El-Agrody, A. M., & El-Mawgoud, H. K. A. (2023). Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P-glycoprotein expression levels. Journal of Enzyme Inhibition and Medicinal Chemistry, 38(1), 2155814. https://doi.org/10.1080/14756366.2022.2155814
   PubMed Web of Science ®Google Scholar
• An, J., Zuo, G. Y., Hao, X. Y., Wang, G. C., & Li, Z. S. (2011). Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 18(11), 990–993. https://doi.org/10.1016/j.phymed.2011.02.013
   PubMed Web of Science ®Google Scholar
• Balasubramaniyan, S., Irfan, N., Senthilkumar, C., Umamaheswari, A., & Puratchikody, A. (2020). The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistant Escherichia coli intended for UTI treatment. New Journal of Chemistry, 44(31), 13308–13318. https://doi.org/10.1039/D0NJ00657B
   Web of Science ®Google Scholar
• Ballatore, C., Huryn, D. M., & Smith, 3rd, A. B. (2013). Carboxylic acid (bio)isosteres in drug design. ChemMedChem, 8(3), 385–395. https://doi.org/10.1002/cmdc.201200585
   PubMed Web of Science ®Google Scholar
• Barrett, M. J., & Login, I. S. (2009). Gemifloxacin-associated neurotoxicity presenting as encephalopathy. The Annals of Pharmacotherapy, 43(4), 782–784. https://doi.org/10.1345/aph.1L621
   PubMed Web of Science ®Google Scholar
• Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., Huang, J., Jones, E., Jones, J., Brown, K. K., Lewis, C. J., May, E. W., Saunders, M. R., Singh, O., Spitzfaden, C. E., … Gwynn, M. N. (2010). Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature, 466(7309), 935–940. https://doi.org/10.1038/nature09197
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, IN., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., Salmon, J. K., Shan, Y., & Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters [Paper presentation]. Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, Association for Computing Machinery, Tampa, Florida, pp. 84. https://doi.org/10.1145/1188455.1188544
   Google Scholar
• Brogan, D. M., & Mossialos, E. (2016). A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility. Globalization and Health, 12, 8.
   PubMed Web of Science ®Google Scholar
• Bush, K., & Pucci, M. J. (2011). New antimicrobial agents on the horizon. Biochemical Pharmacology, 82(11), 1528–1539. https://doi.org/10.1016/j.bcp.2011.07.077
   PubMed Web of Science ®Google Scholar
• Carion, T. W., Ebrahim, A. S., Alluri, S., Ebrahim, T., Parker, T., Burns, J., Sosne, G., & Berger, E. A. (2020). Antimicrobial effects of thymosin beta-4 and ciprofloxacin adjunctive therapy in pseudomonas aeruginosa induced keratitis. International Journal of Molecular Sciences, 21(18), 6840. https://doi.org/10.3390/ijms21186840
   PubMed Web of Science ®Google Scholar
• Coni, P., Piras, M., Mateddu, A., Piludu, M., Orru, G., Scano, A., Cabras, T., Piras, V., Lachowicz, J. I., Jaremko, M., Faa, G., Castagnola, M., & Pichiri, G. (2020). Thymosin β4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study. RSC Advances, 10(21), 12680–12688. https://doi.org/10.1039/c9ra10365a
   PubMed Web of Science ®Google Scholar
• Demirci, F., & Başer, K. H. C. (2002). Bioassay techniques for drug development by Atta-ur-Rahman, M. Iqbal Choudhary (HEJRIC, University of Karachi, Pakistan), William J. Thomsen (Areana Pharmaceuticals, San Diego, CA). Harwood Academic Publishers, Amsterdam, The Netherlands. 2001. xii + 223 pp. 15.5 × 23.5 cm. $79.00. ISBN 90-5823-051-1. Journal of Natural Products, 65(7), 1086–1087. https://doi.org/10.1021/np020725b
   Google Scholar
• Domagala, J. M. (1994). Structure-activity and structure-side-effect relationships for the quinolone antibacterials. The Journal of Antimicrobial Chemotherapy, 33(4), 685–706. https://doi.org/10.1093/jac/33.4.685
   PubMed Web of Science ®Google Scholar
• El-Dakdouki, M. H., & Erhardt, P. W. (2012). Analogue-based drug discovery: Contributions to medicinal chemistry principles and drug design strategies. Microtubule stabilizers as a case in point (Special Topic Article). Pure and Applied Chemistry, 84(7), 1479–1542. https://doi.org/10.1351/PAC-CON-12-02-13
   Web of Science ®Google Scholar
• El-Gamal, K. M., El-Morsy, A. M., Saad, A. M., Eissa, I. H., & Alswah, M. (2018). Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. Journal of Molecular Structure, 1166, 15–33. https://doi.org/10.1016/j.molstruc.2018.04.010
   Web of Science ®Google Scholar
• El-Gamal, M. I., & Oh, C. H. (2010). Current status of carbapenem antibiotics. Current Topics in Medicinal Chemistry, 10(18), 1882–1897. https://doi.org/10.2174/156802610793176639
   PubMed Web of Science ®Google Scholar
• El-Shershaby, M. H., El-Gamal, K. M., Bayoumi, A. H., El-Adl, K., Ahmed, H. E. A., & Abulkhair, H. S. (2021). Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives. Archiv der Pharmazie, 354, 2000277.
   PubMed Web of Science ®Google Scholar
• FDA Approved Drugs; CenterWatch: Boston. (2013). http://www.centerwatch.com/drug-information/fda-approvals.
   Google Scholar
• Fleeman, R., LaVoi, T. M., Santos, R. G., Morales, A., Nefzi, A., Welmaker, G. S., Medina-Franco, J. L., Giulianotti, M. A., Houghten, R. A., & Shaw, L. N. (2015). Combinatorial libraries as a tool for the discovery of novel, broad-spectrum antibacterial agents targeting the ESKAPE pathogens. Journal of Medicinal Chemistry, 58(8), 3340–3355. https://doi.org/10.1021/jm501628s
   PubMed Web of Science ®Google Scholar
• Fouda, A. M., Hassan, A. H., Eliwa, E. M., Ahmed, H. E. A., Al-Dies, A.-A. M., Omar, A. M., Nassar, H. S., Halawa, A. H., Aljuhani, N., & El-Agrody, A. M. (2020). Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase. Bioorganic Chemistry, 105, 104387. https://doi.org/10.1016/j.bioorg.2020.104387
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gaillard, H., Muse, T. G., & Aguilera, A. (2015). Replication stress and cancer. Nature Reviews. Cancer, 15(5), 276–e289. https://doi.org/10.1038/nrc3916
   PubMed Web of Science ®Google Scholar
• Guiol, C., Ledoussal, C., & Surgé, J. M. (1993). Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents. Arzneimittel-Forschung, 43(1), 56–60.
   PubMed Web of Science ®Google Scholar
• Hammad, A., Abutaleb, N. S., Elsebaei, M. M., Norvil, A. B., Alswah, M., Ali, A. O., Abdel-Aleem, J. A., Alattar, A., Bayoumi, S. A., Gowher, H., Seleem, M. N., & Mayhoub, A. S. (2019). From phenylthiazoles to phenylpyrazoles: Broadening the antibacterial spectrum toward carbapenem-resistant bacteria. Journal of Medicinal Chemistry, 62(17), 7998–8010. https://doi.org/10.1021/acs.jmedchem.9b00720
   PubMed Web of Science ®Google Scholar
• Hawash, M., Jaradat, N., Abualhasan, M., Şüküroğlu, M. K., Qaoud, M. T., Kahraman, D. C., Daraghmeh, H., Maslamani, L., Sawafta, M., Ratrout, A., & Issa, L. (2023). Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors. BMC Chemistry, 17(1), 11. https://doi.org/10.1186/s13065-023-00924-3
   PubMed Web of Science ®Google Scholar
• Hogberg, L. D., Heddini, A., & Cars, O. (2010). The global need for effective antibiotics: Challenges and recent advances. Trends in Pharmacological Sciences, 31(11), 509–515. https://doi.org/10.1016/j.tips.2010.08.002
   PubMed Web of Science ®Google Scholar
• Ibrahim, N. M., Fahim, S. H., Hassan, M., Farag, A. E., & Georgey, H. H. (2022). Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects. European Journal of Medicinal Chemistry, 228, 114021. https://doi.org/10.1016/j.ejmech.2021.114021
   PubMed Web of Science ®Google Scholar
• Jakopin, Ž., Ilaš, J., Barančoková, M., Brvar, M., Tammela, P., Sollner Dolenc, M., Tomašič, T., & Kikelj, D. (2017). Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors. European Journal of Medicinal Chemistry, 130, 171–184. https://doi.org/10.1016/j.ejmech.2017.02.046
   PubMed Web of Science ®Google Scholar
• Kamdar, N. R., Haveliwala, D. D., Mistry, P. T., & Patel, S. K. (2011). Synthesis and evaluation of in vitro antitubercular activity and antimicrobial activity of some novel 4H-chromeno[2,3-d]pyrimidine via 2-amino-4-phenyl-4H-chromene-3-carbonitriles. Medicinal Chemistry Research, 20(7), 854–864. https://doi.org/10.1007/s00044-010-9399-x
   Web of Science ®Google Scholar
• Khayat, M. T., Ahmed, H. E. A., Omar, A. M., Muhammad, Y. A., Mohammad, K. A., Malebari, A. M., Khayyat, A. N., Halawa, A. H., Abulkhair, H. S., Al-Karmalawy, A. A., Almaghrabi, M., Alharbi, M., Aljahdali, A. S., & El-Agrody, A. M. (2023). A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses. Journal of Biomolecular Structure & Dynamics, 41, 1–19. https://doi.org/10.1080/07391102.2023.2188957
   PubMedGoogle Scholar
• Kijewska, M., Sharfalddin, A. A., Jaremko, Ł., Cal, M., Setner, B., Siczek, M., Stefanowicz, P., Hussien, M. A., Emwas, A.-H., & Jaremko, M. (2021). Lossen rearrangement of p-toluenesulfonates of N-oxyimides in basic condition, theoretical study, and molecular docking. Frontiers in Chemistry, 9, 662533. https://doi.org/10.3389/fchem.2021.662533
   PubMed Web of Science ®Google Scholar
• Lachowicz, J. I., Jaremko, M., Jaremko, L., Pichiri, G., Coni, P., & Piludu, M. (2019). Metal coordination of thymosin β4: Chemistry and possible implications. Coordination Chemistry Reviews, 396, 117–123. https://doi.org/10.1016/j.ccr.2019.06.008
   Web of Science ®Google Scholar
• Lachowicz, J. I., Pichiri, G., Piludu, M., Fais, S., Orrù, G., Congiu, T., Piras, M., Faa, G., Fanni, D., Dalla Torre, G., Lopez, X., Chandra, K., Szczepski, K., Jaremko, L., Ghosh, M., Emwas, A.-H., Castagnola, M., Jaremko, M., Hannappel, E., & Coni, P. (2022). Thymosin β4 is an endogenous iron chelator and molecular switcher of ferroptosis. International Journal of Molecular Sciences, 23(1), 551. https://doi.org/10.3390/ijms23010551
   PubMed Web of Science ®Google Scholar
• Lentz, S. R. C., Chheda, P. R., Oppegard, L. M., Towle, T. R., Kerns, R. J., & Hiasa, H. (2019). The C7-aminomethylpyrrolidine group rescues the activity of a thio-fluoroquinolone. Biochimie, 160, 24–27. https://doi.org/10.1016/j.biochi.2019.02.002
   PubMed Web of Science ®Google Scholar
• Levine, C., Hiasa, H., & Marians, K. J. (1998). DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochimica et Biophysica Acta, 1400(1–3), 29–43. https://doi.org/10.1016/s0167-4781(98)00126-2
   PubMedGoogle Scholar
• Mahnashi, M. H., El-Senduny, F. F., Alshahrani, M. A., & Abou-Salim, M. A. (2022). Design, synthesis, and biological evaluation of a novel VEGFR-2 inhibitor based on a 1,2,5-oxadiazole-2-oxide scaffold with MAPK signaling pathway inhibition. Pharmaceuticals (Basel, Switzerland), 15(2), 246. https://doi.org/10.3390/ph15020246
   PubMedGoogle Scholar
• Malebari, A. M., Ahmed, H. E. A., Ihmaid, S. K., Omar, A. M., Muhammad, Y. A., Althagfan, S. S., Aljuhani, N., Sayed, A.-A. A. A. El., Halawa, A. H., El-Tahir, H. M., Turkistani, S. A., Almaghrabi, M., Aljohani, A. K. B., El-Agrody, A. M., & Abulkhair, H. S. (2023). Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms. Bioorganic Chemistry, 130, 106255. https://doi.org/10.1016/j.bioorg.2022.106255
   PubMed Web of Science ®Google Scholar
• Maxwell, A., Burton, N. P., & O'Hagan, N. (2006). High-throughput assays for DNA gyrase and other topoisomerases. Nucleic Acids Research, 34(15), e104. https://doi.org/10.1093/nar/gkl504
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). (2012). M. Molecular Operating Environment (MOE) Chemical Computing Group, Quebec, Canada. Retrieved February 30, 2013, from http://www.chemcomp.com.
   Google Scholar
• Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65(1–2), 55–63. https://doi.org/10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., … Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Murray, P. R., & Baron, E. J. (2003). M. American Society for, Manual of clinical microbiology. ASM Press.
   Google Scholar
• Musa, A., Ihmaid, S. K., Hughes, D. L., Said, M. A., Abulkhair, H. S., El-Ghorab, A. H., Abdelgawad, M. A., Shalaby, K., Shaker, M. E., Alharbi, K. S., Alotaibi, N. H., Kays, D. L., Taylor, L. J., Parambi, D. G. T., Alzarea, S. I., Al-Karmalawy, A. A., Ahmed, H. E. A., & El-Agrody, A. M. (2023). The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations. Journal of Biomolecular Structure & Dynamics, 41, 1–15. https://doi.org/10.1080/07391102.2023.2167000
   PubMedGoogle Scholar
• Mustaev, A., Malik, M., Zhao, X., Kurepina, N., Luan, G., Oppegard, L. M., Hiasa, H., Marks, K. R., Kerns, R. J., Berger, J. M., & Drlica, K. (2014). Fluoroquinolone-gyrase-DNA complexes: Two modes of drug binding. The Journal of Biological Chemistry, 289(18), 12300–12312. https://doi.org/10.1074/jbc.M113.529164
   PubMed Web of Science ®Google Scholar
• Omar, A. M., Alswah, M., Ahmed, H. E. A., Bayoumi, A. H., El-Gamal, K. M., El-Morsy, A., Ghiaty, A., Afifi, T. H., Sherbiny, F. F., Mohammed, A. S., & Mansour, B. A. (2020). Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B. Bioorganic Chemistry, 96, 103656. https://doi.org/10.1016/j.bioorg.2020.103656
   PubMed Web of Science ®Google Scholar
• Omar, A. M., Ihmaid, S., Habib, E. E., Althagfan, S. S., Ahmed, S., Abulkhair, H. S., & Ahmed, H. E. A. (2020). The rational design, synthesis, and antimicrobial investigation of 2-Amino-4-Methylthiazole analogues inhibitors of GlcN-6-P synthase. Bioorganic Chemistry, 99, 103781. https://doi.org/10.1016/j.bioorg.2020.103781
   PubMed Web of Science ®Google Scholar
• Omar, F. A., Abelrasoul, M., Sheha, M. M., Hassan, H. Y., & Ibrahiem, Y. M. (2018). Synthesis, antibacterial activity and molecular docking of substituted naphthyridines as potential DNA gyrase inhibitors. ChemistrySelect, 3(9), 2604–2612. https://doi.org/10.1002/slct.201800108
   Web of Science ®Google Scholar
• Okasha, R. M., Alsehli, M., Ihmaid, S., Althagfan, S. S., El-Gaby, M. S. A., Ahmed, H. E. A., & Afifi, T. H. (2019). First example of Azo-Sulfa conjugated chromene moieties: Synthesis, characterization, antimicrobial assessment, docking simulation as potent class I histone deacetylase inhibitors and antitumor agents. Bioorganic Chemistry, 92, 103262. https://doi.org/10.1016/j.bioorg.2019.103262
   PubMed Web of Science ®Google Scholar
• Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011). Carbapenems: Past, present, and future. Antimicrobial Agents and Chemotherapy, 55(11), 4943–4960. https://doi.org/10.1128/AAC.00296-11
   PubMed Web of Science ®Google Scholar
• Patani, G. A., & LaVoie, E. J. (1996). Bioisosterism: A rational approach in drug design. Chemical Reviews, 96(8), 3147–3176. https://doi.org/10.1021/cr950066q
   PubMed Web of Science ®Google Scholar
• Rajanarendar, E., Nagi Reddy, M., Rama Krishna, S., Rama Murthy, K., Reddy, Y. N., & Rajam, M. V. (2012). Design, synthesis, antimicrobial, anti-inflammatory and analgesic activity of novel isoxazolyl pyrimido[4,5-b]quinolines and isoxazolyl chromeno[2,3-d]pyrimidin-4-ones. European Journal of Medicinal Chemistry, 55, 273–283. https://doi.org/10.1016/j.ejmech.2012.07.029
   PubMed Web of Science ®Google Scholar
• Reddy, G. M., Kumari, A. K., Reddy, V. H., & Garcia, J. R. (2020). Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: Design, synthesis, microbial resistance and machine aided results. Bioorganic Chemistry, 100, 103908. https://doi.org/10.1016/j.bioorg.2020.103908
   PubMed Web of Science ®Google Scholar
• Rezki, N., Al-Sodies, S. A., Ahmed, H. E. A., Ihmaid, S., Messali, M., Ahmed, S., & Aouad, M. R. (2019). A novel dicationic ionic liquids encompassing pyridinium hydrazone-phenoxy conjugates as antimicrobial agents targeting diverse high resistant microbial strains. Journal of Molecular Liquids, 284, 431–444. https://doi.org/10.1016/j.molliq.2019.04.010
   Web of Science ®Google Scholar
• Rodriguez, L. G., Duque, A., Castellsague, J., Gutthann, S. P., & Stricker, B. C. (1999). A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. British Journal of Clinical Pharmacology, 48(6), 847–852. https://doi.org/10.1046/j.1365-2125.1999.00095.x
   PubMed Web of Science ®Google Scholar
• Romesberg, F. E., & Craney, A. (2016). Discovery of novel antibacterials. Bioorganic & Medicinal Chemistry, 24(24), 6225–6226. https://doi.org/10.1016/j.bmc.2016.11.046
   PubMed Web of Science ®Google Scholar
• Rusu, A., Munteanu, A. C., Arbănași, E. M., & Uivarosi, V. (2023). Overview of side-effects of antibacterial fluoroquinolones: New drugs versus old drugs, a step forward in the safety profile? Pharmaceutics, 15(3), 804. https://doi.org/10.3390/pharmaceutics15030804
   PubMed Web of Science ®Google Scholar
• Schmuck, G., Schürmann, A., & Schlüter, G. (1998). Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrobial Agents and Chemotherapy, 42(7), 1831–1836. https://doi.org/10.1128/AAC.42.7.1831
   PubMed Web of Science ®Google Scholar
• Seleem, M. A., Disouky, A. M., Mohammad, H., Abdelghany, T. M., Mancy, A. S., Bayoumi, S. A., Elshafeey, A., El-Morsy, A., Seleem, M. N., & Mayhoub, A. S. (2016). Second-generation phenylthiazole antibiotics with enhanced pharmacokinetic properties. Journal of Medicinal Chemistry, 59(10), 4900–4912. https://doi.org/10.1021/acs.jmedchem.6b00233
   PubMed Web of Science ®Google Scholar
• Slobbe, P., Ruijter, E., & Orru, R. V. A. (2012). Recent applications of multicomponent reactions in medicinal chemistry. MedChemComm, 3(10), 1189–1218. https://doi.org/10.1039/c2md20089a
   Web of Science ®Google Scholar
• Smith, D. A. (2010). Metabolism, pharmacokinetics and toxicity of functional groups: Impact of chemical building blocks on ADMET (1st ed., Vol. 1, pp. 201–219). RSC Publishing, Drug Discovery.
   Google Scholar
• Subburaju, S., & Benes, F. M. (2012). Induction of the GABA cell phenotype: An in vitro model for studying neurodevelopmental disorders. PLoS One. 7(3), e33352. https://doi.org/10.1371/journal.pone.0033352
   PubMed Web of Science ®Google Scholar
• Sultana, R., Ali, A., Twala, C., Mehandi, R., Rana, M., Yameen, D., Abid, M., Rahisuddin. (2023). Synthesis, spectral characterization of pyrazole derived Schiff base analogs: Molecular dynamic simulation, antibacterial and DNA binding studies. Journal of Biomolecular Structure & Dynamics, 41, 1–28. https://doi.org/10.1080/07391102.2023.2179541
   PubMedGoogle Scholar
• Sun, J., Lv, P. C., Yin, Y., Yuan, R. J., Ma, J., & Zhu, H. L. (2013). Synthesis, structure and antibacterial activity of potent DNA gyrase inhibitors: N'-benzoyl-3-(4-bromophenyl)-1H-pyrazole-5-carbohydrazide derivatives. PLoS One, 8(7), e69751. https://doi.org/10.1371/journal.pone.0069751
   PubMed Web of Science ®Google Scholar
• Thomas, R. J. (1994). Neurotoxicity of antibacterial therapy. Southern Medical Journal, 87(9), 869–874. https://doi.org/10.1097/00007611-199409000-00001
   PubMed Web of Science ®Google Scholar
• Tomašič, T., Mirt, M., Barancokova, M., Ilas, J., Zidar, N., Tammela, P., & Kikelj, D. (2017). Design, synthesis and biological evaluation of 4, 5-dibromo-N-(thiazol-2-yl)- 1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors. Bioorganic & Medicinal Chemistry, 25(1), 338–349. https://doi.org/10.1016/j.bmc.2016.10.038
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. Jr. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Wang, Y., Du, Y., & Huang, N. (2018). A survey of the role of nitrile groups in protein-ligand interactions. Future Medicinal Chemistry, 10(23), 2713–2728. https://doi.org/10.4155/fmc-2018-0252
   PubMed Web of Science ®Google Scholar
• WHO Report on Cancer. (2020). https://apps.who.int/iris/rest/bitstreams/1267643/retrieve1-160.
   Google Scholar
• Wiegand, I., Hilpert, K., & Hancock, R. E. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols, 3(2), 163–175. https://doi.org/10.1038/nprot.2007.521
   PubMed Web of Science ®Google Scholar
• Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037
   PubMed Web of Science ®Google Scholar
• Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., Chen, X., Hou, T., & Cao, D. (2021). ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research, 49(W1), W5–W14. https://doi.org/10.1093/nar/gkab255
   PubMed Web of Science ®Google Scholar
• Zaghary, W. A., Anwar, M. M., Abd El-Karim, S. S., Awad, G., Hussein, E. A., Mahfouz, G. K., & Design, N. M. (2021). Synthesis and molecular docking of new benzimidazole derivatives of potential antimicrobial activity as DNA gyrase and topoisomerase IV inhibitors. Egyptian Journal of Chemistry, 64, 3817–3839.
   Web of Science ®Google Scholar